NFO Update: TRUST Mutual Fund announces launch of multicap fund
The New Fund Offer or NFO of the fund is open for subscription and will close on July 14.
Also Read | Record inflow of over Rs 15,000 crore in May. What is making arbitrage mutual funds gain investors' interest?
The fund is designed for investors seeking a diversified and disciplined approach to equity investing. The fund offers a comprehensive solution with a focus on long-term capital appreciation and a balanced risk-return profile across market cycles, according to a release by the fund house.The multi cap fund will have a minimum 25% allocation each to large, mid, and small cap stocks, ensuring consistent and structured diversification. Around 40–60 high-conviction stocks across market segments, backed by strong research and conviction
The fund will be benchmarked to NIFTY 500 Multi Cap 50:25:25 TRI, and the stock-picking approach will be focused on identifying potential high growth opportunitiesThe TRUSTMF Multi Cap Fund will follow a disciplined, research-backed investment process that will primarily focus on identifying companies beyond the foreseeable horizon primarily driven by leadership, Intangibles and megatrends, ensures growth-driven stock selection that are reasonably priced to their earnings potential.'The TRUSTMF Multi Cap Fund is a strategic addition to our product suite. By committing to a disciplined allocation across market caps, the fund aims to blend stability, growth, and innovation. It aims to minimize timing biases and offers investors a robust platform for long-term wealth creation,' said Sandeep Bagla, CEO, TRUST Mutual Fund.Also Read | JioBlackRock launches mutual fund access on MyJio, calls it a new era of investing
'The power of compounding unfolds with patience and discipline. Our TRUSTMF Multi Cap Fund harnesses high-conviction ideas across segments using our robust and disciplined equity investment philosophy. This portfolio is built not just to perform through cycles, but to thrive amid India's structural growth story,' said Mihir Vora, CIO, TRUST Mutual Fund. 'India's dynamic equity environment presents diverse opportunities. The TRUSTMF Multi Cap Fund takes a disciplined approach to capture these, aiming to deliver long-term wealth creation opportunities through deep research and market insight,' said Aakash Manghani, Fund Manager – Equities, TRUST Mutual Fund.The fund is suitable for investors seeking long-term capital appreciation and want investment predominantly in equity and equity related instruments across large cap, mid cap, and small cap stocks.
Why a multi cap now?
The fund house focused on a multi cap fund now as it enforces structured exposure of minimum 25% each across all market caps to prevent concentration risk, combines the resilience of large caps with the growth potential of mid and small caps, and minimizes emotional investment decisions and market timing errors.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
37 minutes ago
- Economic Times
Chemkart India IPO: Check GMP, price band and other details
Mumbai's Chemkart India, a B2B food and health ingredient distributor, is launching its IPO today. The company aims to raise Rs 80.08 crore. The IPO includes a fresh issue and an offer for sale. The issue closes on July 9, with BSE SME listing expected on July 14. Proceeds will fund expansion and debt repayment. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Chemkart India, a Mumbai-based B2B distributor of food and health ingredients, will open its IPO today, aiming to raise Rs 80.08 crore through a mix of fresh issue and offer for sale. The three-day issue will close on July 9, with shares expected to list on the BSE SME platform on July IPO comprises a fresh issue of 26 lakh shares aggregating up to Rs 64.48 crore and an offer for sale (OFS) of 6.29 lakh shares worth Rs 15.60 price band is fixed at Rs 236–248 per share, with a lot size of 600 shares. Ahead of the issue opening, the GMP is Rs 0 in the unlisted Horizon Capital Advisors is the lead manager to the issue, with Bigshare Services as registrar. Alacrity Securities is the market in 2015, Chemkart operates in the health and food ingredients segment, supplying amino acids, herbal extracts, vitamins, proteins, and sports nutrition components to supplement company also offers in-house services like grinding, blending, and packaging at its 28,000 sq. ft. facility in Bhiwandi, enhancing its control over quality and IPO proceeds will fund capital expenditure through investment in its wholly owned subsidiary, Easy Raw Materials, repay existing borrowings, and meet general corporate of FY25, Chemkart reported a 55% jump in revenue to Rs 205.46 crore and a 67% rise in profit after tax at Rs 24.26 crore. Its return on equity stands at 59%, with a healthy EBITDA margin of 16.12%.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
News18
an hour ago
- News18
Adani Enterprises To Raise Rs 1,000 Crore Via NCDs; Issue Opens From July 9
Last Updated: Adani Enterprises Limited (AEL) has announced the launch of its second public issuance of non-convertible debentures (NCDs). Adani Enterprises Share Price: Adani Enterprises Limited (AEL) has announced the launch of its second public issue of non-convertible debentures (NCDs), aiming to raise up to Rs 1,000 crore. The base issue size stands at Rs 500 crore, with an option to retain oversubscription up to an additional Rs 500 crore under the green shoe option. The issue will open on July 9, 2025, and close on July 22, 2025. Each NCD will have a face value of Rs 1,000. Investors can apply for a minimum of 10 NCDs, amounting to Rs 10,000, and in multiples of one NCD thereafter. The debentures are proposed to be listed on both the BSE and the National Stock Exchange (NSE), providing liquidity for investors. The proceeds from the NCD issue will be primarily used for debt reduction. AEL has earmarked at least 75% of the net proceeds for prepayment or repayment of existing borrowings. The remaining 25% will be allocated toward general corporate purposes. This structured allocation highlights the company's intent to strengthen its balance sheet while funding strategic initiatives. The NCDs will be offered in tenors of 24 months, 36 months, and 60 months, with interest payment options available on a quarterly, annual, or cumulative basis. There are eight series in total, catering to varied investor preferences. The effective yield ranges between 8.95% and 9.30%, depending on the selected maturity period. AEL had earlier launched its first NCD issue in September 2024, raising Rs 800 crore. That issuance was fully subscribed on the opening day. Commenting on the new offering, Jugeshinder Singh, Group CFO of the Adani Group, said the strong investor response to their debut issue was followed by a credit rating upgrade, which led to capital appreciation for debt investors. He added that AEL is scaling up the next generation of infrastructure businesses across airports, roads, data centres, and the green hydrogen ecosystem. The NCDs have been assigned a rating of 'CARE AA-; Stable" by CARE Ratings, which was upgraded on February 19, 2025, and reaffirmed on June 18, 2025. ICRA has also rated the instruments '\[ICRA]AA- (Stable)", initially assigned on March 28, 2025, and reaffirmed on June 17, 2025. The lead managers for the issue are Nuvama Wealth Management Limited, Trust Investment Advisors Private Limited, and Tipsons Consultancy Services Private Limited. Their role will be crucial in managing subscriptions and ensuring the success of the issue. First Published:
Time of India
an hour ago
- Time of India
Chemkart India IPO: Check GMP, price band and other details
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Chemkart India, a Mumbai-based B2B distributor of food and health ingredients, will open its IPO today, aiming to raise Rs 80.08 crore through a mix of fresh issue and offer for sale. The three-day issue will close on July 9, with shares expected to list on the BSE SME platform on July IPO comprises a fresh issue of 26 lakh shares aggregating up to Rs 64.48 crore and an offer for sale (OFS) of 6.29 lakh shares worth Rs 15.60 price band is fixed at Rs 236–248 per share, with a lot size of 600 shares. Ahead of the issue opening, the GMP is Rs 0 in the unlisted Horizon Capital Advisors is the lead manager to the issue, with Bigshare Services as registrar. Alacrity Securities is the market in 2015, Chemkart operates in the health and food ingredients segment, supplying amino acids, herbal extracts, vitamins, proteins, and sports nutrition components to supplement company also offers in-house services like grinding, blending, and packaging at its 28,000 sq. ft. facility in Bhiwandi, enhancing its control over quality and IPO proceeds will fund capital expenditure through investment in its wholly owned subsidiary, Easy Raw Materials, repay existing borrowings, and meet general corporate of FY25, Chemkart reported a 55% jump in revenue to Rs 205.46 crore and a 67% rise in profit after tax at Rs 24.26 crore. Its return on equity stands at 59%, with a healthy EBITDA margin of 16.12%.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
